Freedom Capital upgraded Biogen shares, and MarketBeat reported the consensus rating for the company.
5 reports, 1 independent
Updated Sep 2
Gone quiet
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Freedom Capital upgraded Biogen shares, and MarketBeat reported the consensus rating for the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Biogen
American multinational biotechnology company
Nothing else this week.
-
Freedom Capital
company in the Czech Republic
-
MarketBeat
American personal finance blog
Related events
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.
- Stock of Professional Diversity Network, Inc. traded on the Nasdaq exchange and was reported by MarketBeat.
- BioHarvest Sciences Inc is listed on the Nasdaq stock exchange and is receiving analyst ratings and targets from MarketBeat.
- MarketBeat provides stock rating data for Vivos Therapeutics, which is listed on Nasdaq.
- Avax One Technology Ltd. stock is traded on the Nasdaq exchange, and MarketBeat reports analyst ratings for the company.